Published in EMBO J on March 06, 2012
FDA-approved selective estrogen receptor modulators inhibit Ebola virus infection. Sci Transl Med (2013) 1.62
TIM-family proteins promote infection of multiple enveloped viruses through virion-associated phosphatidylserine. PLoS Pathog (2013) 1.53
A "Trojan horse" bispecific-antibody strategy for broad protection against ebolaviruses. Science (2016) 1.45
Ecological dynamics of emerging bat virus spillover. Proc Biol Sci (2015) 1.34
Multiple cationic amphiphiles induce a Niemann-Pick C phenotype and inhibit Ebola virus entry and infection. PLoS One (2013) 1.29
Complex lipid trafficking in Niemann-Pick disease type C. J Inherit Metab Dis (2014) 1.20
Structural basis for Marburg virus neutralization by a cross-reactive human antibody. Cell (2015) 1.18
A novel life cycle modeling system for Ebola virus shows a genome length-dependent role of VP24 in virus infectivity. J Virol (2014) 1.13
Filoviruses utilize glycosaminoglycans for their attachment to target cells. J Virol (2013) 1.11
Identification of NPC1 as the target of U18666A, an inhibitor of lysosomal cholesterol export and Ebola infection. Elife (2015) 1.08
A new player in the puzzle of filovirus entry. Nat Rev Microbiol (2012) 1.08
Camouflage and misdirection: the full-on assault of ebola virus disease. Cell (2014) 1.07
Comprehensive functional analysis of N-linked glycans on Ebola virus GP1. MBio (2014) 1.05
Ebola virus and severe acute respiratory syndrome coronavirus display late cell entry kinetics: evidence that transport to NPC1+ endolysosomes is a rate-defining step. J Virol (2014) 1.02
Chromatin landscapes of retroviral and transposon integration profiles. PLoS Genet (2014) 1.02
An update on the use of antibodies against the filoviruses. Immunotherapy (2013) 1.01
Molecular mechanisms of Ebola virus pathogenesis: focus on cell death. Cell Death Differ (2015) 1.00
Spatial localization of the Ebola virus glycoprotein mucin-like domain determined by cryo-electron tomography. J Virol (2014) 0.99
The multiple roles of sGP in Ebola pathogenesis. Viral Immunol (2015) 0.98
Two synthetic antibodies that recognize and neutralize distinct proteolytic forms of the ebola virus envelope glycoprotein. Chembiochem (2012) 0.97
Niemann-Pick C1 (NPC1)/NPC1-like1 chimeras define sequences critical for NPC1's function as a flovirus entry receptor. Viruses (2012) 0.96
Mammalian NPC1 genes may undergo positive selection and human polymorphisms associate with type 2 diabetes. BMC Med (2012) 0.94
Human Ebola virus infection in West Africa: a review of available therapeutic agents that target different steps of the life cycle of Ebola virus. Infect Dis Poverty (2014) 0.94
Filovirus receptor NPC1 contributes to species-specific patterns of ebolavirus susceptibility in bats. Elife (2015) 0.93
Niemann-pick C1 is essential for ebolavirus replication and pathogenesis in vivo. MBio (2015) 0.93
Ebola virus entry: a curious and complex series of events. PLoS Pathog (2015) 0.93
Structural and molecular basis for Ebola virus neutralization by protective human antibodies. Science (2016) 0.92
A mutation in the Ebola virus envelope glycoprotein restricts viral entry in a host species- and cell-type-specific manner. J Virol (2013) 0.91
Host cell factors in filovirus entry: novel players, new insights. Viruses (2012) 0.91
Towards detection and diagnosis of Ebola virus disease at point-of-care. Biosens Bioelectron (2015) 0.91
Role of EXT1 and Glycosaminoglycans in the Early Stage of Filovirus Entry. J Virol (2015) 0.90
Structure of human Niemann-Pick C1 protein. Proc Natl Acad Sci U S A (2016) 0.89
Ebolavirus Glycoprotein Directs Fusion through NPC1+ Endolysosomes. J Virol (2015) 0.89
Forty years of the war against Ebola. J Zhejiang Univ Sci B (2014) 0.89
Less is more: Ebola virus surface glycoprotein expression levels regulate virus production and infectivity. J Virol (2014) 0.88
Host-Primed Ebola Virus GP Exposes a Hydrophobic NPC1 Receptor-Binding Pocket, Revealing a Target for Broadly Neutralizing Antibodies. MBio (2016) 0.88
Haploid Genetic Screen Reveals a Profound and Direct Dependence on Cholesterol for Hantavirus Membrane Fusion. MBio (2015) 0.88
Shedding light on filovirus infection with high-content imaging. Viruses (2012) 0.87
Cell entry by a novel European filovirus requires host endosomal cysteine proteases and Niemann-Pick C1. Virology (2014) 0.87
Chemical and Structural Aspects of Ebola Virus Entry Inhibitors. ACS Infect Dis (2014) 0.87
Direct Visualization of Ebola Virus Fusion Triggering in the Endocytic Pathway. MBio (2016) 0.87
The Ebola virus matrix protein VP40 selectively induces vesiculation from phosphatidylserine-enriched membranes. J Biol Chem (2014) 0.86
Ebolavirus entry requires a compact hydrophobic fist at the tip of the fusion loop. J Virol (2014) 0.86
Ebola virus exploits a monocyte differentiation program to promote its entry. J Virol (2013) 0.86
Inhibition of Ebola Virus Infection: Identification of Niemann-Pick C1 as the Target by Optimization of a Chemical Probe. ACS Med Chem Lett (2012) 0.85
Interferon-γ Inhibits Ebola Virus Infection. PLoS Pathog (2015) 0.85
Lassa-vesicular stomatitis chimeric virus safely destroys brain tumors. J Virol (2015) 0.84
Analysis of Ebola Virus Entry Into Macrophages. J Infect Dis (2015) 0.84
Interaction between TIM-1 and NPC1 Is Important for Cellular Entry of Ebola Virus. J Virol (2015) 0.83
Antibody Treatment of Ebola and Sudan Virus Infection via a Uniquely Exposed Epitope within the Glycoprotein Receptor-Binding Site. Cell Rep (2016) 0.83
Role of endosomes and lysosomes in human disease. Cold Spring Harb Perspect Biol (2014) 0.83
Lipids: a key player in the battle between the host and microorganisms. J Lipid Res (2012) 0.82
Clues to the mechanism of cholesterol transfer from the structure of NPC1 middle lumenal domain bound to NPC2. Proc Natl Acad Sci U S A (2016) 0.82
Ebola virus entry into host cells: identifying therapeutic strategies. Curr Clin Microbiol Rep (2015) 0.82
Development of novel entry inhibitors targeting emerging viruses. Expert Rev Anti Infect Ther (2012) 0.82
The cytosolic adaptor AP-1A is essential for the trafficking and function of Niemann-Pick type C proteins. Traffic (2013) 0.82
Structural characterization of the glycoprotein GP2 core domain from the CAS virus, a novel arenavirus-like species. J Mol Biol (2013) 0.82
Mapping of Ebolavirus Neutralization by Monoclonal Antibodies in the ZMapp Cocktail Using Cryo-Electron Tomography and Studies of Cellular Entry. J Virol (2016) 0.81
Comparative Analysis of Host Cell Entry of Ebola Virus From Sierra Leone, 2014, and Zaire, 1976. J Infect Dis (2015) 0.81
AMP-activated protein kinase is required for the macropinocytic internalization of ebolavirus. J Virol (2012) 0.80
Fusion of Enveloped Viruses in Endosomes. Traffic (2016) 0.80
Endocytic pathways involved in filovirus entry: advances, implications and future directions. Viruses (2012) 0.79
Analysis of Lujo virus cell entry using pseudotype vesicular stomatitis virus. J Virol (2014) 0.79
Hunting Viral Receptors Using Haploid Cells. Annu Rev Virol (2015) 0.79
In vitro assembly of Ebola virus nucleocapsid-like complex expressed in E. coli. Protein Cell (2016) 0.79
Predictive and comparative analysis of Ebolavirus proteins. Cell Cycle (2015) 0.79
Conserved differences in protein sequence determine the human pathogenicity of Ebolaviruses. Sci Rep (2016) 0.78
Novel Small Molecule Entry Inhibitors of Ebola Virus. J Infect Dis (2015) 0.78
Cysteine Cathepsin Inhibitors as Anti-Ebola Agents. ACS Infect Dis (2016) 0.77
The ins and outs of viral infection: keystone meeting review. Viruses (2014) 0.77
Induction of Cell-Cell Fusion by Ebola Virus Glycoprotein: Low pH Is Not a Trigger. PLoS Pathog (2016) 0.77
Applications of DNA integrating elements: Facing the bias bully. Mob Genet Elements (2015) 0.76
Conformational properties of peptides corresponding to the ebolavirus GP2 membrane-proximal external region in the presence of micelle-forming surfactants and lipids. Biochemistry (2013) 0.76
Infectious Entry Pathway Mediated by the Human Endogenous Retrovirus K Envelope Protein. J Virol (2016) 0.76
Chasing Ebola through the Endosomal Labyrinth. MBio (2016) 0.76
DNA topoisomerase 1 facilitates the transcription and replication of the Ebola virus genome. J Virol (2013) 0.76
Selective inhibition of Ebola entry with selective estrogen receptor modulators by disrupting the endolysosomal calcium. Sci Rep (2017) 0.75
Structure of the Ebola virus glycoprotein spike within the virion envelope at 11 Å resolution. Sci Rep (2017) 0.75
A Single Residue in Ebola Virus Receptor NPC1 Influences Cellular Host Range in Reptiles. mSphere (2016) 0.75
Genetic Dissection of the Host Tropism of Human-Tropic Pathogens. Annu Rev Genet (2015) 0.75
Cellular factors implicated in filovirus entry. Adv Virol (2013) 0.75
A CRISPR toolbox to study virus-host interactions. Nat Rev Microbiol (2017) 0.75
Clues to NPC1-mediated cholesterol export from lysosomes. Proc Natl Acad Sci U S A (2016) 0.75
Cell-cell contact promotes Ebola virus GP-mediated infection. Virology (2015) 0.75
Analyses of Entry Mechanisms of Novel Emerging Viruses Using Pseudotype VSV System. Trop Med Health (2014) 0.75
Ebola virus mediated infectivity is restricted in canine and feline cells. Vet Microbiol (2015) 0.75
The phosphatidylinositol-3-phosphate 5-kinase inhibitor apilimod blocks filoviral entry and infection. PLoS Negl Trop Dis (2017) 0.75
Technologies for Proteome-Wide Discovery of Extracellular Host-Pathogen Interactions. J Immunol Res (2017) 0.75
Endosomal proteolysis of the Ebola virus glycoprotein is necessary for infection. Science (2005) 7.07
Efficient recovery of infectious vesicular stomatitis virus entirely from cDNA clones. Proc Natl Acad Sci U S A (1995) 6.95
A system for functional analysis of Ebola virus glycoprotein. Proc Natl Acad Sci U S A (1997) 6.86
Niemann-Pick C1 disease gene: homology to mediators of cholesterol homeostasis. Science (1997) 6.66
Ebola virus entry requires the cholesterol transporter Niemann-Pick C1. Nature (2011) 5.68
Structures and mechanisms of viral membrane fusion proteins: multiple variations on a common theme. Crit Rev Biochem Mol Biol (2008) 5.26
Structure of the Ebola virus glycoprotein bound to an antibody from a human survivor. Nature (2008) 5.24
Characterization of Ebola virus entry by using pseudotyped viruses: identification of receptor-deficient cell lines. J Virol (1998) 5.16
Identification of HE1 as the second gene of Niemann-Pick C disease. Science (2000) 5.08
Murine model of Niemann-Pick C disease: mutation in a cholesterol homeostasis gene. Science (1997) 4.55
C-type lectins DC-SIGN and L-SIGN mediate cellular entry by Ebola virus in cis and in trans. J Virol (2002) 4.47
Role of endosomal cathepsins in entry mediated by the Ebola virus glycoprotein. J Virol (2006) 4.24
Distinct cellular interactions of secreted and transmembrane Ebola virus glycoproteins. Science (1998) 4.24
Proposal for a revised taxonomy of the family Filoviridae: classification, names of taxa and viruses, and virus abbreviations. Arch Virol (2010) 3.77
Small molecule inhibitors reveal Niemann-Pick C1 is essential for Ebola virus infection. Nature (2011) 3.66
Evaluation of immune globulin and recombinant interferon-alpha2b for treatment of experimental Ebola virus infections. J Infect Dis (1999) 3.62
Ebola virus can be effectively neutralized by antibody produced in natural human infection. J Virol (1999) 3.44
Structure of N-terminal domain of NPC1 reveals distinct subdomains for binding and transfer of cholesterol. Cell (2009) 3.24
DC-SIGN and DC-SIGNR bind ebola glycoproteins and enhance infection of macrophages and endothelial cells. Virology (2003) 3.20
NPC2 facilitates bidirectional transfer of cholesterol between NPC1 and lipid bilayers, a step in cholesterol egress from lysosomes. Proc Natl Acad Sci U S A (2008) 2.81
Ebolavirus is internalized into host cells via macropinocytosis in a viral glycoprotein-dependent manner. PLoS Pathog (2010) 2.60
Cellular entry of ebola virus involves uptake by a macropinocytosis-like mechanism and subsequent trafficking through early and late endosomes. PLoS Pathog (2010) 2.60
Conserved receptor-binding domains of Lake Victoria marburgvirus and Zaire ebolavirus bind a common receptor. J Biol Chem (2006) 2.56
Comprehensive analysis of ebola virus GP1 in viral entry. J Virol (2005) 2.56
Mutational analysis of the putative fusion domain of Ebola virus glycoprotein. J Virol (1999) 2.41
Folate receptor-alpha is a cofactor for cellular entry by Marburg and Ebola viruses. Cell (2001) 2.39
Purified NPC1 protein: II. Localization of sterol binding to a 240-amino acid soluble luminal loop. J Biol Chem (2007) 2.34
Genetic evidence for nonredundant functional cooperativity between NPC1 and NPC2 in lipid transport. Proc Natl Acad Sci U S A (2004) 2.32
Tyro3 family-mediated cell entry of Ebola and Marburg viruses. J Virol (2006) 2.24
Proteolysis of the Ebola virus glycoproteins enhances virus binding and infectivity. J Virol (2007) 2.16
The primed ebolavirus glycoprotein (19-kilodalton GP1,2): sequence and residues critical for host cell binding. J Virol (2009) 2.15
T-cell immunoglobulin and mucin domain 1 (TIM-1) is a receptor for Zaire Ebolavirus and Lake Victoria Marburgvirus. Proc Natl Acad Sci U S A (2011) 2.12
The intracellular transport of low density lipoprotein-derived cholesterol is inhibited in Chinese hamster ovary cells cultured with 3-beta-[2-(diethylamino)ethoxy]androst-5-en-17-one. J Biol Chem (1989) 2.04
Consequences of NPC1 and NPC2 loss of function in mammalian neurons. Biochim Biophys Acta (2004) 2.00
Ebola virus glycoprotein 1: identification of residues important for binding and postbinding events. J Virol (2007) 1.93
A forward genetic strategy reveals destabilizing mutations in the Ebolavirus glycoprotein that alter its protease dependence during cell entry. J Virol (2010) 1.87
The asialoglycoprotein receptor is a potential liver-specific receptor for Marburg virus. J Gen Virol (1995) 1.76
Evidence for a Niemann-pick C (NPC) gene family: identification and characterization of NPC1L1. Genomics (2000) 1.69
The niemann-pick disease genes; regulators of cellular cholesterol homeostasis. Trends Cardiovasc Med (2004) 1.67
Biochemical and structural characterization of cathepsin L-processed Ebola virus glycoprotein: implications for viral entry and immunogenicity. J Virol (2010) 1.62
Role of Niemann-Pick type C1 protein in intracellular trafficking of low density lipoprotein-derived cholesterol. J Biol Chem (2000) 1.56
Cathepsin cleavage potentiates the Ebola virus glycoprotein to undergo a subsequent fusion-relevant conformational change. J Virol (2011) 1.46
The Tyro3 receptor kinase Axl enhances macropinocytosis of Zaire ebolavirus. J Virol (2010) 1.36
Niemann-Pick type C 1 function requires lumenal domain residues that mediate cholesterol-dependent NPC2 binding. Proc Natl Acad Sci U S A (2011) 1.35
Monovalent virus-like particle vaccine protects guinea pigs and nonhuman primates against infection with multiple Marburg viruses. Expert Rev Vaccines (2008) 1.23
Membrane topology of human NPC1L1, a key protein in enterohepatic cholesterol absorption. J Lipid Res (2009) 1.16
Cell adhesion-dependent membrane trafficking of a binding partner for the ebolavirus glycoprotein is a determinant of viral entry. Proc Natl Acad Sci U S A (2010) 1.14
The structure and function of the Niemann-Pick C1 protein. Mol Genet Metab (2000) 1.07
The subcellular localization of the Niemann-Pick Type C proteins depends on the adaptor complex AP-3. J Cell Sci (2007) 1.05
Detection of cell-cell fusion mediated by Ebola virus glycoproteins. J Virol (2006) 0.98
Targeting of NPC1 to late endosomes involves multiple signals, including one residing within the putative sterol-sensing domain. J Biol Chem (2004) 0.89
Phenylalanines at positions 88 and 159 of Ebolavirus envelope glycoprotein differentially impact envelope function. Virology (2009) 0.86
A genomic and functional inventory of deubiquitinating enzymes. Cell (2005) 9.36
Regulation of progenitor cell proliferation and granulocyte function by microRNA-223. Nature (2008) 8.69
A large-scale RNAi screen in human cells identifies new components of the p53 pathway. Nature (2004) 8.67
YAP1 increases organ size and expands undifferentiated progenitor cells. Curr Biol (2007) 8.11
Endosomal proteolysis of the Ebola virus glycoprotein is necessary for infection. Science (2005) 7.07
Endocytosis by random initiation and stabilization of clathrin-coated pits. Cell (2004) 6.75
Ebola virus entry requires the cholesterol transporter Niemann-Pick C1. Nature (2011) 5.68
Peroxisomes are signaling platforms for antiviral innate immunity. Cell (2010) 5.24
Haploid genetic screens in human cells identify host factors used by pathogens. Science (2009) 4.91
Subcapsular sinus macrophages in lymph nodes clear lymph-borne viruses and present them to antiviral B cells. Nature (2007) 4.88
Yap1 acts downstream of α-catenin to control epidermal proliferation. Cell (2011) 4.85
Specific inhibition of gene expression using a stably integrated, inducible small-interfering-RNA vector. EMBO Rep (2003) 4.52
The deubiquitinating enzyme USP1 regulates the Fanconi anemia pathway. Mol Cell (2005) 4.40
Lipid raft microdomains: a gateway for compartmentalized trafficking of Ebola and Marburg viruses. J Exp Med (2002) 3.88
Subcapsular sinus macrophages prevent CNS invasion on peripheral infection with a neurotropic virus. Nature (2010) 3.71
Small molecule inhibitors reveal Niemann-Pick C1 is essential for Ebola virus infection. Nature (2011) 3.66
A functional screen implicates microRNA-138-dependent regulation of the depalmitoylation enzyme APT1 in dendritic spine morphogenesis. Nat Cell Biol (2009) 3.44
Postexposure antibody prophylaxis protects nonhuman primates from filovirus disease. Proc Natl Acad Sci U S A (2012) 3.35
Human immunodeficiency virus type 1 escapes from RNA interference-mediated inhibition. J Virol (2004) 3.23
Ebola and Marburg viruses replicate in monocyte-derived dendritic cells without inducing the production of cytokines and full maturation. J Infect Dis (2003) 3.15
Visualization of Rab9-mediated vesicle transport from endosomes to the trans-Golgi in living cells. J Cell Biol (2002) 3.03
The impact of target site accessibility on the design of effective siRNAs. Nat Biotechnol (2008) 2.51
A broad-spectrum antiviral targeting entry of enveloped viruses. Proc Natl Acad Sci U S A (2010) 2.41
Lactobacilli activate human dendritic cells that skew T cells toward T helper 1 polarization. Proc Natl Acad Sci U S A (2005) 2.35
In vivo oligomerization and raft localization of Ebola virus protein VP40 during vesicular budding. Proc Natl Acad Sci U S A (2003) 2.32
Journeys through the Golgi--taking stock in a new era. J Cell Biol (2009) 2.30
Structure of the reovirus membrane-penetration protein, Mu1, in a complex with is protector protein, Sigma3. Cell (2002) 2.24
Global gene disruption in human cells to assign genes to phenotypes by deep sequencing. Nat Biotechnol (2011) 2.23
An antiviral role for the RNA interference machinery in Caenorhabditis elegans. Proc Natl Acad Sci U S A (2005) 2.16
Yip3 catalyses the dissociation of endosomal Rab-GDI complexes. Nature (2003) 2.15
Rab and Arl GTPase family members cooperate in the localization of the golgin GCC185. Cell (2008) 2.09
Generation of iPSCs from cultured human malignant cells. Blood (2010) 1.99
Deciphering the glycosylome of dystroglycanopathies using haploid screens for lassa virus entry. Science (2013) 1.91
A mitotic phosphorylation feedback network connects Cdk1, Plk1, 53BP1, and Chk2 to inactivate the G(2)/M DNA damage checkpoint. PLoS Biol (2010) 1.90
A forward genetic strategy reveals destabilizing mutations in the Ebolavirus glycoprotein that alter its protease dependence during cell entry. J Virol (2010) 1.87
A shared structural solution for neutralizing ebolaviruses. Nat Struct Mol Biol (2011) 1.84
Dendritic cells endocytose Bacillus anthracis spores: implications for anthrax pathogenesis. J Immunol (2005) 1.78
MCT1-mediated transport of a toxic molecule is an effective strategy for targeting glycolytic tumors. Nat Genet (2012) 1.70
Putative autocleavage of outer capsid protein micro1, allowing release of myristoylated peptide micro1N during particle uncoating, is critical for cell entry by reovirus. J Virol (2004) 1.69
shRNA libraries and their use in cancer genetics. Nat Methods (2006) 1.66
A senescence rescue screen identifies BCL6 as an inhibitor of anti-proliferative p19(ARF)-p53 signaling. Genes Dev (2002) 1.65
A syntaxin 10-SNARE complex distinguishes two distinct transport routes from endosomes to the trans-Golgi in human cells. J Cell Biol (2008) 1.63
Virus nomenclature below the species level: a standardized nomenclature for natural variants of viruses assigned to the family Filoviridae. Arch Virol (2012) 1.59
A functional role for the GCC185 golgin in mannose 6-phosphate receptor recycling. Mol Biol Cell (2006) 1.54
Infectious Lassa virus, but not filoviruses, is restricted by BST-2/tetherin. J Virol (2010) 1.48
Inhibition of metalloprotease botulinum serotype A from a pseudo-peptide binding mode to a small molecule that is active in primary neurons. J Biol Chem (2006) 1.47
Identification of host cell factors required for intoxication through use of modified cholera toxin. J Cell Biol (2011) 1.47
Mechanical tension can specify axonal fate in hippocampal neurons. J Cell Biol (2002) 1.46
E2F-7: a distinctive E2F family member with an unusual organization of DNA-binding domains. Oncogene (2004) 1.44
Multiple Rab GTPase binding sites in GCC185 suggest a model for vesicle tethering at the trans-Golgi. Mol Biol Cell (2008) 1.43
Anticancer kinase inhibitors impair intracellular viral trafficking and exert broad-spectrum antiviral effects. J Clin Invest (2017) 1.39
Convalescent Plasma and the Dose of Ebola Virus Antibodies. N Engl J Med (2017) 1.38
Clues to neuro-degeneration in Niemann-Pick type C disease from global gene expression profiling. PLoS One (2006) 1.37
Putative autocleavage of reovirus mu1 protein in concert with outer-capsid disassembly and activation for membrane permeabilization. J Mol Biol (2005) 1.37
Mouse hepatitis coronavirus RNA replication depends on GBF1-mediated ARF1 activation. PLoS Pathog (2008) 1.36
TBC1D20 is a Rab1 GTPase-activating protein that mediates hepatitis C virus replication. J Biol Chem (2007) 1.36
Niemann-Pick type C 1 function requires lumenal domain residues that mediate cholesterol-dependent NPC2 binding. Proc Natl Acad Sci U S A (2011) 1.35
Protective cytotoxic T-cell responses induced by venezuelan equine encephalitis virus replicons expressing Ebola virus proteins. J Virol (2005) 1.35
Cyclophosphamide increases transgene expression mediated by an oncolytic adenovirus in glioma-bearing mice monitored by bioluminescence imaging. Mol Ther (2006) 1.32
Cholesterol accumulation sequesters Rab9 and disrupts late endosome function in NPC1-deficient cells. J Biol Chem (2006) 1.31
Influenza-virus membrane fusion by cooperative fold-back of stochastically induced hemagglutinin intermediates. Elife (2013) 1.31
Lipolysis-stimulated lipoprotein receptor (LSR) is the host receptor for the binary toxin Clostridium difficile transferase (CDT). Proc Natl Acad Sci U S A (2011) 1.31
A haploid genetic screen identifies the major facilitator domain containing 2A (MFSD2A) transporter as a key mediator in the response to tunicamycin. Proc Natl Acad Sci U S A (2011) 1.30
Peptides released from reovirus outer capsid form membrane pores that recruit virus particles. EMBO J (2008) 1.30
Protection of nonhuman primates against two species of Ebola virus infection with a single complex adenovirus vector. Clin Vaccine Immunol (2010) 1.29
Ebola virus genome plasticity as a marker of its passaging history: a comparison of in vitro passaging to non-human primate infection. PLoS One (2012) 1.28
Cytotoxic T cells mediate pathology and metastasis in cutaneous leishmaniasis. PLoS Pathog (2013) 1.28
Discussions and decisions of the 2012–2014 International Committee on Taxonomy of Viruses (ICTV) Filoviridae Study Group, January 2012–June 2013. Arch Virol (2014) 1.27
Chemical modifications of antisense morpholino oligomers enhance their efficacy against Ebola virus infection. Antimicrob Agents Chemother (2009) 1.26
RUTBC1 protein, a Rab9A effector that activates GTP hydrolysis by Rab32 and Rab33B proteins. J Biol Chem (2011) 1.25
The viral sigma1 protein and glycoconjugates containing alpha2-3-linked sialic acid are involved in type 1 reovirus adherence to M cell apical surfaces. J Virol (2003) 1.24
RhoBTB3: a Rho GTPase-family ATPase required for endosome to Golgi transport. Cell (2009) 1.23
Ebola virus uses clathrin-mediated endocytosis as an entry pathway. Virology (2010) 1.23
The Ebola virus glycoprotein mediates entry via a non-classical dynamin-dependent macropinocytic pathway. Virology (2011) 1.22
A nonreplicating subunit vaccine protects mice against lethal Ebola virus challenge. Proc Natl Acad Sci U S A (2011) 1.21
Filoviruses require endosomal cysteine proteases for entry but exhibit distinct protease preferences. J Virol (2012) 1.21